Related Experiment Video
Updated: Mar 18, 2026
04:43
COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
596
Saudi adults satisfaction with community pharmacy services
Mohamad Al-Tannir1, Afnan I Alharbi2, Arwa S Alfawaz2
1Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.
Springerplus
|July 8, 2016
Summary
Saudi adults show varied satisfaction with community pharmacy services. Enhancing pharmacist training on patient counseling, especially regarding comorbid diseases, is crucial for improving satisfaction.
Area of Science:
- Pharmacy Practice
- Patient Counseling
- Healthcare Services
Background:
- Community pharmacists are vital in Saudi Arabia's healthcare system, providing essential medication counseling.
- Assessing patient satisfaction and needs is key to improving community pharmacy services.
Purpose of the Study:
- To evaluate Saudi adults' satisfaction with community pharmacy services.
- To understand patient needs regarding pharmacist counseling.
Main Methods:
- A cross-sectional survey was conducted using questionnaires.
- 650 Saudi adults in Riyadh were approached, with 500 completing the survey (77% response rate).
Main Results:
- Only 41% of participants were satisfied with community pharmacy services.
- Satisfaction drivers included medication counseling (57%), dosage explanation (96%), and time spent (73%).
- Dissatisfaction stemmed from lack of comorbidity inquiry (82%) and unavailable dedicated counselors (78%).
Conclusions:
- Saudi adults report variable satisfaction with community pharmacy services.
- Improving satisfaction necessitates enhanced pharmacist training, particularly in addressing comorbid conditions and dedicated counseling.
Related Concept Videos
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
300
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
300
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
318
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
318
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
246
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
246
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
793
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
793
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
309
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
309
01:19Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K